Use of a biosimilar G-CSF in allogeneic stem cell mobilisation

被引：0
|
作者：
Azar, N. [1 ]
Choquet, S. [1 ]
Garnier, A. [1 ]
Weil, D. Roos [1 ]
Leblond, V. [1 ]
机构：
[1] Hop La Pitie Salpetriere, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [1] Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation
    Pahnke, Simon
    Egeland, Torstein
    Halter, Jorg
    Hagglund, Hans
    Shaw, Bronwen E.
    Woolfrey, Ann E.
    Szer, Jeff
    BONE MARROW TRANSPLANTATION, 2019, 54 (06) : 858 - 866
  • [2] Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation
    Simon Pahnke
    Torstein Egeland
    Jörg Halter
    Hans Hägglund
    Bronwen E Shaw
    Ann E Woolfrey
    Jeff Szer
    Bone Marrow Transplantation, 2019, 54 : 858 - 866
  • [3] Use of the G-CSF Biosimilar Ratiograstim® to Mobilize Peripheral Stem Cells in Healthy Donors for Allogeneic Stem Cell Transplantation
    Schmitt, Michael
    Lena, Diestel
    Schneider, Catarina
    Xu, Xun
    Borchert, Kersten
    Glaeser, Dietrich
    Hilgendorf, Inken
    Scheuerlein, Robert
    Freund, Mathias
    Schmitt, Anita
    BLOOD, 2011, 118 (21) : 840 - 840
  • [4] Use Of Biosimilar G-CSF Compared With Lenograstim In Autologous Haematopoietic Stem Cell Transplant and In Sibling Allogeneic Transplant
    Uddin, Shab
    Russell, Pippa
    Farrell, Maresa
    Davy, Barbara
    Agrawal, Samir G.
    BLOOD, 2013, 122 (21)
  • [5] Use of pegylated G-CSF for stem cell mobilisation and harvesting in myeloma patients
    Yap, E. S.
    Soh, T. G.
    Lim, K.
    Tan, B.
    Mah, J.
    Tan, L. K.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S242 - S242
  • [6] Comparable efficacy and safety of biosimilar and originator G-CSF in patients undergoing haematopoietic stem cell mobilisation
    Dmoszynska, A.
    Manko, J.
    Croneck, A.
    Grzasko, N.
    Klimek, P.
    Nowaczynska, A.
    Gorska-Kosicka, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S231 - S232
  • [7] Application of the G-CSF biosimilar Ratiograstim® for the mobilisation of peripheral stem cells in healthy donors
    Schmitt, M.
    Diestel, L.
    Xu, X.
    Borchert, K.
    Glaeser, D.
    Hilgendorf, I
    Scheuerlein, R.
    Freund, M.
    Schmitt, A.
    ONKOLOGIE, 2011, 34 : 280 - 280
  • [8] Biosimilar G-CSF (filgrastim) is also efficient for peripheral blood stem cell mobilisation and no cryopreserved autologous transplantation
    Yafour, N.
    Osmani, S.
    Talhi, S.
    Brahimi, M.
    Hebbar, A.
    Bekadja, S.
    Mehalli, S.
    Benmir, I.
    Arabi, A.
    Bouhass, R.
    Bekadja, M. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S243 - S243
  • [9] Mobilisation of PBSC for Allogenic Transplantation By the Use of G-CSF Biosimilar Zarzio® in Healthy Donors
    Anguita, Javier
    Balsalobre, Pascual
    Gonzalez-Arias, Elena
    Redondo, Sara
    Perez-Corral, Ana
    Pascual, Cristina
    Serrano, David
    Kwon, Mi
    Bastos, Mariana
    MuAoz, Cristina
    Gayoso, Jorge
    Luis Diez-Martin, Jose
    BLOOD, 2014, 124 (21)
  • [10] G-CSF in Healthy Allogeneic Stem Cell Donors
    Hoelig, Kristina
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (04) : 225 - 235
12345